C-reactive protein and primary prevention of ischemic heart disease

Clinica Chimica Acta

Volumn 311, Issue 1, 2001, Pages 45-48

  Liuzzo, Giovanna ^a   Rizzello, Vittoria ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Inflammatory conditions; LDL cholesterol; Primary prevention; Status; Vascular risk

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CERIVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC VALUE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STROKE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; MYOCARDIAL ISCHEMIA; RISK ASSESSMENT;

EID: 0035884874     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00557-5     Document Type: Conference Paper

References (25)

1. The phenomenon of the acute phase response
2. Acute phase proteins withspecial reference to C-reactive Protein and related proteins (pentaxins) and plasma amyloid A protein
3. The liver as the site of C-reactive protein formation
4. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
5. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
6. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
7. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
8. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in myocardial infarction
9. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
10. Independent prognostic value of elevated C-reactive protein in unstable angina
11. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris
12. Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis
13. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
14. Independent prognostic value of CRP levels for in-hospital death and myocardial infarction in unstable angina
15. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
16. Meilahn for the MRFIT research group: Relation of C-reactive protein and coronary heart disease in the MIRFT nested case-control study
17. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
18. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
19. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease initially healthy middle-aged men
20. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
21. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events (CARE) Investigators
22. Long-term effects of pravastatin on plasma concentration of C-reactive protein
23. Direct proinflammatory effect of C-reactive protein on human endothelial cells
24. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia
25. Lovastatin 20-40 mg/day lowers high sensitivity C-reactive protein levels in AFCAPS/TexCAPS